Skip to main content

Table 4 Prevalence of severe somatic, psychological and urogenital symptoms and OR (95% CI) for its association with menopausal status

From: How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

  Severe somatic symptoms Severe psychological symptoms Severe urogenital symptoms
  Crude Adjusteda   Crude Adjusteda   Crude Adjusteda
N (%) OR [95% CI] OR [95% CI] N (%) OR [95% CI] OR [95% CI] N (%) OR [95% CI] OR [95% CI]
Pre-menopause (N = 44) 2 (4.5%) 1 1 6 (13.6%) 1 1 3 (6.8%) 1 1
Peri-menopause (N = 70) 7 (10.0%) 2.33 [0.46–11.82] 3.79 [0.79–18.24] 13 (18.6%) 1.44 [0.54–3.89] 2.31 [0.79–6.80] 6 (8.6%) 1.28 [0.38–5.22] 1.00 [0.27–3.74]
Post-menopause (N = 137) 10 (7.3%) 1.65 [0.31–8.82] 2.35 [0.45–12.86] 28 (20.4%) 1.63 [0.54–4.88] 1.96 [0.47–8.08] 34 (24.8%) 4.51 [1.42–14.3] 4.90 [1.74–13.84]
p value 0.554    0.602    0.002   
  1. Bold values are statistically significant
  2. OR: Odds Ratio from logistic regression for the association between menopausal status and the presence of severe menopausal symptoms in each MRS domain
  3. aAdjusted for mode of transmission, current occupational status, smoking, drug use, social support, current partner